» Authors » Lawrence Purpura

Lawrence Purpura

Explore the profile of Lawrence Purpura including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 165
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Masuda K, Iketani S, Liu L, Huang J, Qiao Y, Shah J, et al.
bioRxiv . 2025 Jan; PMID: 39868279
Although emerging data have revealed the critical role of memory CD8 T cells in preventing and controlling SARS-CoV-2 infection, virus-specific CD8 T-cell responses against SARS-CoV-2 and its memory and innate-like...
2.
Blackett J, Elkind M, OByrne S, Wainberg M, Purpura L, Chang L, et al.
Gastro Hep Adv . 2024 Aug; 2(7):918-924. PMID: 39130764
Background And Aims: It is unclear to what degree post-COVID-19 gastrointestinal (GI) symptoms are caused by the SARS-CoV-2 virus vs psychological factors related to the stress of the pandemic. To...
3.
Blackett J, Sun Y, Purpura L, Margolis K, Elkind M, OByrne S, et al.
Clin Transl Gastroenterol . 2022 Sep; 13(10):e00524. PMID: 36049050
Introduction: An estimated 15%-29% of patients report new gastrointestinal (GI) symptoms after coronavirus-19 disease (COVID-19) while 4%-31% report new depressive symptoms. These symptoms may be secondary to gut microbiome tryptophan...
4.
Zucker J, Purpura L, Sani F, Huang S, Schluger A, Ruperto K, et al.
AIDS Patient Care STDS . 2022 Mar; 36(3):106-114. PMID: 35289689
Efforts to end the HIV and hepatitis C virus (HCV) epidemics begin with ascertainment of a person's infection status through screening. Despite its importance as a site of testing, missed...
5.
Purpura L, Zucker J, Lasota E, Lopez M, Spicehandler R, Carnevale C, et al.
Open Forum Infect Dis . 2021 Aug; 8(8):ofab411. PMID: 34430675
Multiplex polymerase chain reaction testing for gastrointestinal pathogens was performed on a longitudinal cohort of 110 men who have sex with men taking human immunodeficiency virus preexposure prophylaxis. At least...
6.
Shoucri S, Purpura L, DeLaurentis C, Adan M, Theodore D, Irace A, et al.
BMJ Open . 2021 Jun; 11(6):e049488. PMID: 34083350
Objective: To characterise the long-term outcomes of patients with COVID-19 admitted to a large New York City medical centre at 3 and 6 months after hospitalisation and describe their healthcare...
7.
Pereira M, Arcasoy S, Farr M, Mohan S, Emond J, Tsapepas D, et al.
Transpl Infect Dis . 2021 May; 23(4):e13637. PMID: 33993630
Whether solid organ transplant (SOT) recipients are at increased risk of poor outcomes due to COVID-19 in comparison to the general population remains uncertain. In this study, we compared outcomes...
8.
Knust B, Brown S, de St Maurice A, Whitmer S, Koske S, Ervin E, et al.
J Infect Dis . 2020 Jun; 222(8):1311-1319. PMID: 32484879
Background: During 2017, a multistate outbreak investigation occurred after the confirmation of Seoul virus (SEOV) infections in people and pet rats. A total of 147 humans and 897 rats were...
9.
Nyakarahuka L, de St Maurice A, Purpura L, Ervin E, Balinandi S, Tumusiime A, et al.
PLoS Negl Trop Dis . 2018 May; 12(5):e0006412. PMID: 29723189
Background: Rift Valley fever (RVF) is a zoonotic disease caused by Rift Valley fever virus (RVFV) found in Africa and the Middle East. Outbreaks can cause extensive morbidity and mortality...
10.
de St Maurice A, Nyakarahuka L, Purpura L, Ervin E, Tumusiime A, Balinandi S, et al.
PLoS Negl Trop Dis . 2018 Mar; 12(3):e0006175. PMID: 29505579
Background: Rift Valley Fever virus (RVF) is a zoonotic virus in the Phenuiviridae family. RVF outbreaks can cause significant morbidity and mortality in humans and animals. Following the diagnosis of...